RA Capital Management

Ra Capital Management as of Dec. 31, 2015

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 37 positions in its portfolio as reported in the December 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Achillion Pharmaceuticals 12.0 $121M 11M 10.79
Wave Life Sciences (WVE) 11.2 $113M 7.1M 15.95
Dyax 10.1 $102M 2.7M 37.62
Axovant Sciences 8.9 $90M 5.0M 18.03
Aclaris Therapeutics (ACRS) 6.8 $69M 2.6M 26.94
Tg Therapeutics (TGTX) 3.3 $34M 2.8M 11.93
Zogenix 3.3 $33M 2.3M 14.74
BioCryst Pharmaceuticals (BCRX) 3.2 $32M 3.1M 10.32
Ascendis Pharma A S (ASND) 3.0 $31M 1.7M 18.32
Regulus Therapeutics 3.0 $30M 3.5M 8.72
Coherus Biosciences (CHRS) 2.9 $29M 1.3M 22.96
Dicerna Pharmaceuticals 2.9 $29M 2.4M 11.87
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 2.3 $24M 858k 27.50
Blueprint Medicines (BPMC) 2.3 $23M 878k 26.34
Proteon Therapeutics 2.3 $23M 1.5M 15.51
Strongbridge Bioph shs usd 2.0 $20M 2.7M 7.60
Sangamo Biosciences (SGMO) 2.0 $20M 2.2M 9.13
Aquinox Pharmaceuticals 2.0 $20M 1.6M 12.48
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) 2.0 $20M 1.2M 17.16
Alcobra 1.9 $19M 3.0M 6.28
Arena Pharmaceuticals 1.6 $17M 8.7M 1.90
Global Blood Therapeutics In 1.5 $15M 457k 32.33
Aimmune Therapeutics 1.4 $15M 790k 18.45
Dimension Therapeutics 1.2 $12M 1.1M 11.28
Ardelyx (ARDX) 1.0 $10M 571k 18.12
Pronai Therapeutics 0.9 $9.1M 605k 15.04
Natera (NTRA) 0.8 $8.5M 784k 10.80
Tenax Therapeutics 0.8 $7.8M 2.4M 3.28
Vitae Pharmaceuticals 0.6 $5.8M 321k 18.10
Zynerba Pharmaceuticals 0.5 $5.1M 507k 10.07
Applied Genetic Technol Corp C 0.5 $4.8M 236k 20.40
Nivalis Therapeutics 0.5 $4.7M 613k 7.74
Akari Therapeutics 0.4 $3.8M 264k 14.50
Arca Biopharma 0.4 $3.6M 778k 4.65
Derma Sciences 0.3 $2.9M 641k 4.57
Neuroderm Ltd F 0.2 $2.5M 145k 17.05
Ampliphi Biosciences 0.0 $213k 54k 3.97